Member Log In
Contact Us
Learn More
Mission & History
Leadership
Supporting Global Healthcare
New York Pharma Foum Photo Gallery
Contact Us
Become a Member
Why Join?
How to Join
List of Member Companies
Events
Upcoming Events
Past Monthly Programs
Previous General Assemblies
Annual Meetings
Biopharma Industry Webinars
Sponsorship Opportunities
Sponsors
Resources
Industry Resources
Member Company News
Ebooks
Biopharma Industry Whitepapers
Videos
Links of Interest
Member Directory*
Presentation Archives*
Media
Blog
Pharma Forum Dialogues
New York Pharma Forum to Hold "Japan Life Sciences Showcase" - Leading Japanese Scientists Explore Partnering Opportunities in the US
New York Pharma Forum Holds Symposium on Pharma's Commitment to Global Health
バイオシミラー初の米国連邦最高裁における司法審査
The First Supreme Court Review of a Biosimilar Case
5 Most-Read Pharma Forum Dialogues Blog Posts of 2015
New York Pharma Forum Holds Symposium on the Reinvention of Pharma
American & Japanese Pharma Companies To Explore Reinvention of Pharma
The Roots of Disruptive Innovation: Healthcare and Beyond
Court Decision Clarifies Hatch-Waxman Data Exclusivity
Softgel Formulations - An Elegant Vehicle for Commercial Success
Double Your Dose of Social Media and Call Me in the Morning
New York Pharma Forum’s Top 3 Most-Read Blog Posts of 2014
FDA Adopts New Procedures for Evaluating Names of Drug Products
Impact of the U.S. Foreign Corrupt Practices Act on Japanese Pharma
New York Pharma Forum 25th General Assembly: "The Future of Aging"
NY Attorney General Sues Forest Laboratories for “Product Hopping”
Japanese Drug Industry's &
Big Pharma's 25-Year Journey
Happy Birthday, New York Pharma Forum!
Two FDA Citizen Petitions Granted Regarding Manufacturer Speech
FDA Releases Draft Guidance on New Risk Information for Approved Drugs
Pain Drug Development to Address High Unmet Need
Background on and Trends in Ethnic Bridging Studies
Inter Partes Review Adds
Another Twist To Hatch-Waxman Litigation
Welcome to the Pharma Forum Dialogues Blog
All posts
Submit A Blog Post
Follow Us
Subscribe to Email Updates
Recent Posts
Posts by Topic
pharma
(4)
FDA guidance
(3)
healthcare
(3)
innovation
(3)
patent law
(3)
BPCIA
(2)
Clinical Trials
(2)
Hatch-Waxman Litigation
(2)
Supreme Court
(2)
biosimilars
(2)
new york
(2)
pharmaceutical
(2)
Generics
(1)
Inter Partes Review
(1)
entrepreneur
(1)
global health
(1)
news
(1)
see all